協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/04/26 | 2,372 | 2,373 | 2,341 | 2,359 | -8 | -0.3% | 887,900 |
2018/04/25 | 2,365 | 2,382 | 2,356 | 2,367 | +2 | +0.1% | 832,700 |
2018/04/24 | 2,377 | 2,394 | 2,351 | 2,365 | +30 | +1.3% | 927,900 |
2018/04/23 | 2,377 | 2,381 | 2,332 | 2,335 | -38 | -1.6% | 818,500 |
2018/04/20 | 2,379 | 2,396 | 2,362 | 2,373 | -3 | -0.1% | 810,800 |
2018/04/19 | 2,376 | 2,420 | 2,365 | 2,376 | +12 | +0.5% | 1,321,000 |
2018/04/18 | 2,360 | 2,408 | 2,339 | 2,364 | +12 | +0.5% | 1,472,700 |
2018/04/17 | 2,393 | 2,402 | 2,345 | 2,352 | -66 | -2.7% | 923,100 |
2018/04/16 | 2,402 | 2,421 | 2,389 | 2,418 | +44 | +1.9% | 628,300 |
2018/04/13 | 2,405 | 2,444 | 2,362 | 2,374 | +17 | +0.7% | 1,281,600 |
2018/04/12 | 2,347 | 2,383 | 2,347 | 2,357 | +19 | +0.8% | 985,100 |
2018/04/11 | 2,392 | 2,398 | 2,316 | 2,338 | -72 | -3% | 1,198,600 |
2018/04/10 | 2,462 | 2,478 | 2,404 | 2,410 | -38 | -1.6% | 1,383,600 |
2018/04/09 | 2,443 | 2,471 | 2,418 | 2,448 | +4 | +0.2% | 1,233,000 |
2018/04/06 | 2,442 | 2,464 | 2,416 | 2,444 | -17 | -0.7% | 1,743,100 |
2018/04/05 | 2,415 | 2,475 | 2,400 | 2,461 | +80 | +3.4% | 1,788,400 |
2018/04/04 | 2,347 | 2,392 | 2,341 | 2,381 | +50 | +2.1% | 1,917,900 |
2018/04/03 | 2,250 | 2,340 | 2,237 | 2,331 | +55 | +2.4% | 1,735,500 |
2018/04/02 | 2,326 | 2,330 | 2,275 | 2,276 | -61 | -2.6% | 914,400 |
2018/03/30 | 2,316 | 2,364 | 2,312 | 2,337 | +50 | +2.2% | 1,557,400 |
2018/03/29 | 2,271 | 2,324 | 2,266 | 2,287 | +40 | +1.8% | 1,517,400 |
2018/03/28 | 2,217 | 2,251 | 2,207 | 2,247 | +3 | +0.1% | 1,037,500 |
2018/03/27 | 2,201 | 2,256 | 2,193 | 2,244 | +73 | +3.4% | 1,488,100 |
2018/03/26 | 2,125 | 2,173 | 2,124 | 2,171 | +20 | +0.9% | 1,143,000 |
2018/03/23 | 2,185 | 2,217 | 2,145 | 2,151 | -106 | -4.7% | 2,273,000 |
2018/03/22 | 2,220 | 2,266 | 2,215 | 2,257 | +25 | +1.1% | 1,013,200 |
2018/03/20 | 2,219 | 2,240 | 2,209 | 2,232 | ±0 | ±0% | 1,056,100 |
2018/03/19 | 2,242 | 2,247 | 2,201 | 2,232 | -32 | -1.4% | 1,051,200 |
2018/03/16 | 2,271 | 2,280 | 2,235 | 2,264 | +18 | +0.8% | 1,677,800 |
2018/03/15 | 2,242 | 2,250 | 2,215 | 2,246 | -5 | -0.2% | 777,900 |
2018/03/14 | 2,218 | 2,254 | 2,216 | 2,251 | +19 | +0.9% | 1,180,800 |
2018/03/13 | 2,185 | 2,232 | 2,184 | 2,232 | +22 | +1% | 830,700 |
2018/03/12 | 2,230 | 2,233 | 2,194 | 2,210 | +27 | +1.2% | 808,500 |
2018/03/09 | 2,187 | 2,227 | 2,171 | 2,183 | +22 | +1% | 2,028,800 |
2018/03/08 | 2,196 | 2,202 | 2,149 | 2,161 | +3 | +0.1% | 1,369,500 |
2018/03/07 | 2,147 | 2,171 | 2,137 | 2,158 | -11 | -0.5% | 1,709,100 |
2018/03/06 | 2,122 | 2,174 | 2,108 | 2,169 | +25 | +1.2% | 1,762,400 |
2018/03/05 | 2,131 | 2,157 | 2,130 | 2,144 | -3 | -0.1% | 1,283,000 |
2018/03/02 | 2,160 | 2,182 | 2,140 | 2,147 | -63 | -2.9% | 2,033,200 |
2018/03/01 | 2,257 | 2,259 | 2,201 | 2,210 | -60 | -2.6% | 1,968,000 |
2018/02/28 | 2,320 | 2,333 | 2,269 | 2,270 | -81 | -3.4% | 2,360,900 |
2018/02/27 | 2,361 | 2,369 | 2,324 | 2,351 | +10 | +0.4% | 1,815,300 |
2018/02/26 | 2,328 | 2,348 | 2,316 | 2,341 | +58 | +2.5% | 1,127,100 |
2018/02/23 | 2,285 | 2,307 | 2,254 | 2,283 | +23 | +1% | 1,481,000 |
2018/02/22 | 2,252 | 2,273 | 2,236 | 2,260 | -7 | -0.3% | 1,748,100 |
2018/02/21 | 2,287 | 2,305 | 2,246 | 2,267 | -61 | -2.6% | 1,873,600 |
2018/02/20 | 2,337 | 2,354 | 2,318 | 2,328 | -22 | -0.9% | 1,423,100 |
2018/02/19 | 2,340 | 2,371 | 2,335 | 2,350 | +28 | +1.2% | 1,033,400 |
2018/02/16 | 2,314 | 2,355 | 2,304 | 2,322 | -7 | -0.3% | 1,813,100 |
2018/02/15 | 2,263 | 2,342 | 2,263 | 2,329 | +73 | +3.2% | 1,570,500 |
1601~
1650
件表示中 / 3581件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 257,000円 | +11.3% | -5.4% | 2.26% | 19.78倍 | 1.56倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
塩野義 | 214,000円 | +5.7% | +3.9% | 2.68% | 10.65倍 | 1.41倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 502,900円 | +1.7% | -2.9% | 3.18% | 32.99倍 | 1.73倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 181,500円 | -3.5% | -50.2% | 4.41% | 14.70倍 | 1.09倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 274,400円 | +18.2% | +4.2% | 1.20% | 19.45倍 | 2.48倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
市場注目の銘柄
チャート関連のコラム